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Leptin secreted by adipocytes acts on the brain to
reduce food intake by regulating neuronal activity in
the mediobasal hypothalamus (MBH). Obesity is
associated with resistance to high circulating leptin
levels. Here, we demonstrate that peripherally
administered leptin activates its receptor (LepR) in
median eminence tanycytes followed by MBH neu-
rons, a process requiring tanycytic ERK signaling
and the passage of leptin through the cerebrospinal
fluid. In mice lacking the signal-transducing LepRb
isoform or with diet-induced obesity, leptin taken
up by tanycytes accumulates in the median
eminence and fails to reach the MBH. Triggering
ERK signaling in tanycytes with EGF reestablishes
leptin transport, elicits MBH neuron activation and
energy expenditure in obese animals, and acceler-
ates the restoration of leptin sensitivity upon the
return to a normal-fat diet. ERK-dependent leptin
transport by tanycytes could thus play a critical role
in the pathophysiology of leptin resistance, and
holds therapeutic potential for treating obesity.
INTRODUCTION
Leptin, a 16 kDa peptide hormone mainly produced by adipo-
cytes, is present in serum at levels directly proportional to the
amount of adipose tissue, and controls food intake by activating
LepR signaling in the brain (Ahima and Flier, 2000; de Luca et al.,
2005). In leptin-deficient humans and mice, leptin administration
effectively reduces hyperphagia and obesity (Campfield et al.,
1995; Farooqi et al., 1999; Halaas et al., 1995; Pelleymounter
et al., 1995). Paradoxically, most cases of obesity display high
circulating leptin levels that fail to reduce appetite or increase en-
ergy expenditure (Frederich et al., 1995). The mechanisms un-
derlying this leptin resistance are unclear but potentially include
its defective transport across the blood-brain barrier to the cere-
brospinal fluid (CSF) (Caro et al., 1996; Schwartz et al., 1996) orCell Mto its sites of action within the CNS (Van Heek et al., 1997), and
failure of the LepR signaling cascade (El-Haschimi et al., 2000;
Enriori et al., 2007; Mu¨nzberg and Myers, 2005).
Exogenous leptin given peripherally, for example, intraperito-
neally (i.p.), first activates select neurons in the hypothalamic
arcuate nucleus (ARH) (Faouzi et al., 2007), amajor leptin-sensing
site (Coppari et al., 2005; Cowley et al., 2001), and after a 1–2 hr
lag, triggers LepR signaling in more dorsal hypothalamic sites
that control energy homeostasis (Faouzi et al., 2007). Intriguingly,
leptin given intracerebroventricularly (i.c.v.) activates all leptin-
responsive hypothalamic neurons within minutes (Faouzi et al.,
2007), suggesting that the passage of leptin from the periphery
to the CSF could act as an important physiological checkpoint
in the intrahypothalamic propagation of leptin signaling.
We have recently shown that tanycytes, specialized hypotha-
lamic glia located in a circumventricular organ adjoining the
ARH—the median eminence (ME)—and extending from the
ependymal surface of the third ventricle to a plexus of permeable
fenestrated vessels at the pial surface of the brain, form a barrier
between the blood and CSF (Langlet et al., 2013; Mullier et al.,
2010). Although structural changes to this barrier modulate the
access of blood-borne metabolic signals to ventromedial ARH
neurons and, consequently, adaptive responses to acute nutri-
tional challenges (Langlet et al., 2013; Schaeffer et al., 2013),
the process by which these factors gain access to hypothalamic
circuits that regulate energy balance under normal conditions is
largely unknown.
Here, we explored the idea that the ME could serve as the
route for leptin entry into the hypothalamus, and that tanycytes
man this checkpoint. In addition, we investigated whether leptin
transport is altered in mice with diet-induced obesity (DIO) and
by what molecular mechanisms. Lastly, we asked whether
normal transport could be restored by pharmacological means,
and if this rescue would improve leptin sensitivity in DIO mice.RESULTS
The ME Is the First Hypothalamic Site Reached
by Peripheral Leptin
Leptinergic signaling involves various pathways, including
STAT3, ERK, and PI3K/Akt (Robertson et al., 2008).We studiedetabolism 19, 293–301, February 4, 2014 ª2014 Elsevier Inc. 293
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C57Bl/6 mice by immunohistochemistry for phosphorylated
STAT3 (pSTAT3) at various times after peripheral leptin adminis-
tration (3 mg/kg). Strikingly, 5 min after i.p. injection, pSTAT3
immunoreactivity (IR) was detected in both tanycytic processes,
which contact the capillary plexus at the pial surface of the brain
(Langlet et al., 2013; Mullier et al., 2010), and their nuclei,
whereas pSTAT3-IR in neurons was infrequent and weak (Fig-
ure 1A). By 15 min after injection, while some tanycytes were still
labeled, pSTAT3-IR in neurons dramatically increased; at longer
intervals, pSTAT3-IR occurred almost exclusively in neurons
(Figures 1A and 1B). Thus, circulating leptin appears to sequen-
tially activate LepR in ME tanycytes followed by neurons.
Next, we studied the role of the ME in hypothalamic leptin up-
take bywestern blotting of theME and of theMBH containing the
ARH, microdissected frommice 5, 15, and 45 min after i.p. leptin
injection (see Figures S1A and S1B available online). Exogenous
leptin was detected only in the ME at 5 min (Figure S1C) but pro-
gressively invaded the MBH at 15 and 45 min (Figure 1C).
Concurrently, STAT3 was activated in the ME alone at 15 min
and in both the ME and MBH at 45 min; pSTAT3 was not detect-
able at earlier time points in either compartment (Figures 1C,
S1C, and S1D), suggesting that the ME is the first hypothalamic
site accessed by peripheral leptin.
To determine whether DIO (El-Haschimi et al., 2000; Enriori
et al., 2007) altered leptin uptake, we redid these experiments
in mice with leptin resistance following a 9-week high-fat diet
(Figures S2A and S2B). DIO profoundly disrupted leptin access
to the MBH but not the ME, although leptin failed to activate
STAT3 in theME of thesemice (Figure 1C). Instead, as previously
shown (Enriori et al., 2011; Martin et al., 2006), there was some
constitutive STAT3 activity in the MBH (Figure 1C), including in
numerous ARH neurons, and to a lesser extent in ME tanycytes,
in vehicle- and leptin-treated DIO mice (Figures 1B and S2C).
However, neither cell type displayed any further increase in
pSTAT3-IR following leptin treatment, suggesting that leptin
resistance involves defective LepR signaling in both hypotha-
lamic tanycytes and neurons.
Interestingly, mice lacking the signaling-competent LepRb
isoform (db/db mice) phenocopied DIO mice, with blood-borne
exogenous leptin remaining blocked in the ME in both lean juve-
niles and obese adults (Figures S1E and 1C). Next, we i.p. in-
jected standard-chow-fed WTmice with a mutated recombinant
leptin antagonist (LAN) with no biological activity but unmodified
LepR-binding properties (Niv-Spector et al., 2005). While LAN
was as readily detected by western blotting as bioactive leptin
(Figure S1G), it did not accumulate in theME orMBH (Figure 1D),
confirming that LepR function is required for peripheral leptin to
access the ME and MBH.
Blood-Borne Leptin Is Taken Up by ME Tanycytes
To determine the role of tanycytes in hypothalamic leptin uptake
in vivo, we intravenously administered fluorescently labeled
bioactive leptin (16 kDa) (Vauthier et al., 2013) to standard-
chow-fed WT mice 5 min before sacrifice. At this short interval,
fluorescent leptin was seen exclusively in ME tanycytes in the
brain parenchyma, and virtually all ME tanycytes were labeled
(Figure 1E). While this labeling occurred mainly in tanycytic cell
bodies along the floor of the third ventricle, in a few cases a ta-294 Cell Metabolism 19, 293–301, February 4, 2014 ª2014 Elsevier Innycytic process stretching to the pial surface was also labeled,
indicating that blood-borne leptin is likely taken up by tanycytic
end-feet and transported toward the cell body in contact with
the CSF (Figure 1E). In contrast, fluorescently labeled LAN was
never seen in tanycytic cell bodies or processes, indicating
that LepR activation is required for this uptake.
Passage of Blood-Borne Leptin to the CSF Is Required
for STAT3 Activation in MBH Neurons
We next examined the putative contribution of the passage of
systemic leptin into the CSF to STAT3 activation inMBH neurons
in vivo, by administering neutralizing antibodies to leptin
(20 mg/2 ml/animal) i.c.v. 10 min before injecting leptin (3 mg/kg
i.p., 45 min). Importantly, neutralizing antibodies did not diffuse
into the hypothalamic tissue, but instead were sometimes found
to bind lightly toME tanycytes (Figure S2D). This neutralization of
leptin in the CSF, while it might not have been extensive or
exhaustive, significantly hampered the leptin-induced increase
in neuronal p-STAT3-IR in the ARH, ventromedial (VMH), and
dorsomedial (DMH) nuclei of the hypothalamus (Figure 1F), indi-
cating that the passage of leptin from the blood to the CSF is
implicated in the leptin-mediated activation of hypothalamic
neurons.
Tanycytic LepR Is Required for Leptin Uptake
We further explored the role of tanycytic LepR signaling in the
passage of peripheral leptin to the hypothalamus using primary
cultures of rat tanycytes, which we have previously extensively
characterized (Prevot et al., 2003). RT-PCR and sequence anal-
ysis revealed that cultured tanycytes expressed mRNAs for
LepRa, LepRb, LepRc, and LepRe (Figure 2A). Importantly, after
15 min of leptin treatment, tanycytes displayed STAT3, Akt, and
ERK phosphorylation (Figure 2B), demonstrating functional
LepRb signaling. In addition, cultured tanycytes internalized
fluorescent bioactive leptin through clathrin-coated vesicles,
known to exist in tanycytes in vivo (Peruzzo et al., 2004), as
shown by immunocytochemistry (Figure 2C) and western blot-
ting of immunoprecipitated clathrin-coated vesicles (Figure 2D).
However, this leptin internalization was blocked neither by selec-
tive pharmacological antagonists to the various LepRb-related
signaling pathways (U0126 to inhibit MEKK1, the upstream acti-
vator of ERK; LY294002 to inhibit PI3K; and WP1066 to inhibit
STAT3) (Figures 2D and S3A), nor by AG490, an inhibitor of
JAK2 autophosphorylation, the well-studied ‘‘first’’ event in the
LepR signaling cascade (data not shown). In conjunction with
the lack of LAN uptake (Figure 2D), these results strongly indicate
that leptin internalization involves an as-yet-unexplored LepR-
dependent but JAK2-independent mechanism.
Tanycytic Release of Captured Leptin Requires ERK
Signaling
Next, we assessed the fate of fluorescent bioactive leptin, once
internalized, using videomicroscopy. Cultured tanycytes are
highly polarized, like their in vivo counterparts, with cell bodies
attached to the coverslip and extending20 mm-long processes
into the medium. Fluorescent leptin was taken up by tanycytic
end-feet and gradually transported toward the cell body, where
it accumulated (Figure 2E), confirming our in vivo observations of
labeled processes touching the pial surface and demonstratingc.
Figure 1. Leptin Transport into the MBH via the ME
Requires LepR Signaling and Is Disrupted in DIO
Mice
(A) Representative photomicrographs showing pSTAT3-IR
(red) in the ME of adult male WT mice 5, 15, and 45 min
after i.p. leptin administration (3 mg/kg). Arrowheads and
empty arrowheads show pSTAT3-IR in tanycyte cell
bodies lining the floor of the third ventricle (3V) and tany-
cytic processes contacting the pial surface of the brain
(asterisk), respectively. Arrows show neurons immunore-
active for HuC/D (green) and pSTAT3.
(B) Graphs representing the mean number of ME tanycytes
and arcuate neurons labeled for pSTAT3 per hemisection,
15 and 45 min after the i.p. administration of leptin
(3 mg/kg) or vehicle in control (CTL; white bars) and DIO
mice (red bars). p < 0.05 for a versus b and c versus d and
e; ns, not statistically different.
(C) Representative western blots (WB; left) and quantitative
comparison (right panels) of phosphorylated and total
STAT3 and leptin in ME and MBH explants from adult male
WT, DIO, and db/db mice 15 and 45 min after i.p. leptin
(3 mg/kg) or vehicle administration (Veh) (n = 3–4
per group). p < 0.001 for a versus b; p < 0.05 for d versus e.
ND, not detected.
(D) Similar experiments as in (B), performed with WT mice
45 min after the i.p. administration of bioactive leptin or the
mutated antagonist LAN (3 mg/kg) (n = 3–4 per group).
(E) Representative photomicrographs showing tanycytic
processes (arrows) and cell bodies (arrowheads) labeled
by fluorescent leptin (25 nmoles/animal; white labeling),
but not fluorescent LAN (25 nmoles/animal), 5 min after i.v.
injection. However, fluorescent LAN labels blood vessels in
the external zone of the ME and the ARH, as does fluo-
rescent leptin (asterisk).
(F) Representative photomicrographs and quantitative
comparison of pSTAT3-IR (white) in the ARH, VMH, and
DMH of mice treated i.c.v. with vehicle or leptin-neutral-
izing antibodies (Leptin-Ab, n = 5) 45 min after the i.p.
administration of leptin (3 mg/kg), or vehicle (n = 3–5 per
group). Scale bars, 20 mm (A), 100 mm (E), and 200 mm (F).
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 leptin
versus vehicle treatment and between indicated groups.
Values indicate means ± SEM. See also Figures S1, S2,
and S4.
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Figure 2. ME Tanycytes Express Functional LepR, Internalize Leptin through Clathrin-Coated Vesicles, and Release Captured Leptin via an
ERK-Dependent Signaling Pathway
(A) RT-PCR analysis of the expression of mRNAs for LepR isoforms in primary cultures of tanycytes.
(legend continued on next page)
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default direction for clathrin-mediated transport in tanycytes is
basal/apical. Intriguingly, the intensity of the fluorescent signal
decreased over time to reach extinction (Figure 2E), suggesting
that captured leptin was eventually released. Accordingly, when
tanycytes were loaded with leptin (1 mg/ml, 15 min), washed with
PBS, and leptin release monitored 5 and 15 min later, leptin
levels in the medium gradually increased (Figures 2F and S3B),
a process that involved intracellular vesicular trafficking, as
shown by its reversible suppression by colchicine (Figure S3B).
While LY294002 and WP1066 had no effect, U0126 led to leptin
accumulation in tanycytes (Figure 2F), indicating that its release
requires LepRb-ERK signaling.
ERK Signaling Activation in Tanycytes Rescues Leptin
Transport and Function in the MBH of Obese Mice
We next verified whether defective leptin translocation from the
ME to the MBH of obese mice could be rectified by activating
the ERK pathway and thus reinstating leptin release, using
epidermal growth factor (EGF) to activate ERK because of the
abundant expression of erbB1 in tanycytes (Prevot et al.,
2003). EGF treatment (1 mg/kg, 15 min) markedly activated
ERK in ME tanycytes (Figure 3A). Strikingly, leptin treatment fol-
lowed by EGF acutely restored peripheral leptin uptake by the
MBH of db/db and DIO mice (Figure 3B) as well as STAT3 acti-
vation in hypothalamic neurons of DIO mice (Figure 3C). In
contrast, replacing DIO mice on a normal diet, previously shown
to normalize body weight and restore leptin sensitivity over time
(Enriori et al., 2007), only restored leptin transport into the hypo-
thalamus after several weeks (Figures 4A–4C). Daily EGF treat-
ment (i.p., 1 mg/kg) in DIO mice during the last week of their
high-fat diet, which significantly increased energy expenditure
and locomotor activity (Figures 3D–3F), also accelerated weight
loss (with significant effects visible within 1 week of EGF treat-
ment versus 3 weeks with dietary changes alone) and restoration
of leptin sensitivity upon their return to a normal diet (Figures 4A–
4C). These data raise the exciting possibility that ERK activation
could rescue leptin signaling and function in obese mice with
diet-induced leptin resistance (Coppari et al., 2005; Mesaros
et al., 2008).
DISCUSSION
Leptin transport into the brain appears to be a limiting step in the
modulation of its central effects, and it participates in leptin resis-
tance both in humans and rodents (Caro et al., 1996; El-Haschimi
et al., 2000;Schwartz et al., 1996; VanHeek et al., 1997).Our find-(B) Representative WB and quantitative comparison of phosphorylated and tota
nycytes (n = 4 per group).
(C) Representative confocal images for clathrin-IR (green) in tanycytes treated fo
(D) Representative WB and quantitative comparison of leptin and clathrin in immu
with vehicle, LAN (1 mg/ml), or leptin (1 mg/ml) in the presence or absence of U01
(E) Representative live-cell imaging of fluorescent leptin distribution within tanycy
the cultured tanycytes that were analyzed. (Right panel) xz reconstruction of secti
administration. The green and black arrowheads show individual cells that are
(Bottom panel) Representative fluorescence profile in a single cell 15, 30, and 45
(F) Representative WB and quantitative comparison of leptin in cell lysates from l
presence or absence of the pharmacological inhibitors of LepR signaling pathway
0.001 for a versus b. *p < 0.05; ***p < 0.001 treated versus control and indicated
Cell Mings suggest, intriguingly, that blood-borne leptin enters the brain
through the hypothalamic ME, and that tanycytes, which capture
leptin from the bloodstream, act as a checkpoint along this route.
Indeed, our finding that leptin-neutralizing antibodies infused
into the third ventricle impede hypothalamic neuron activation
indicates that tanycyte-mediated leptin transport between the
periphery and the CSF is necessary for its downstream effects.
Technological advances that allow the assessment of subtle
and rapid physiological variations in leptin levels in tiny volumes
of CSF will no doubt help confirm or refine these observations.
Once past this tanycytic checkpoint and in the CSF, the polarity
and barrier properties of ARH tanycytes, which differ from those
of ME tanycytes (Mullier et al., 2010), could allow leptin and
possibly other blood-borne signals to freely enter the ARH and,
subsequently, other hypothalamic regions, by paracellular diffu-
sion. Interestingly, tanycytic cell bodies lining the third ventricle
wall at the level of theME are nonciliated (Mullier et al., 2010), un-
like their more dorsal counterparts (Mullier et al., 2010), poten-
tially creating aquiescent zone that limits signal dispersal through
the CSF and creates a favorable diffusion gradient for their entry
into theadjacentARH.However, beyond the immediate vicinity of
theMEandARH,CSF-borne signals can be redistributed to other
sites of action in the brain by the beating of ciliated ependymal
cells (Sawamoto et al., 2006; Conductier et al., 2013). Indeed,
in our mice, fluorescent leptin from the CSF reaches not only
the hypothalamus but also other downstream target areas known
to be leptin sensitive, such as the hippocampus (Figure S4)
(Harvey, 2007). Interestingly, while our recent work shows that
ARH tanycytes together with fenestratedMEmicrovessels them-
selves constitute ahighly plastic blood-hypothalamusbarrier that
responds to blood-borne metabolic signals by VEGF-A-medi-
ated changes in permeability (Langlet et al., 2013), the beating
of ciliated ependymal cells is also controlled by a hypothalamic
peptide involved in energy metabolism, melanin-concentrating
hormone, released by lateral hypothalamic area neurons
(Conductier et al., 2013) efferent to leptin-sensitive ARH neurons
(Elias et al., 1998). Thus, fenestrated endothelial cells, ME and
‘‘inverted’’ ARH tanycytes, and ciliated ependymal cells together
constitute a highly sensitive ‘‘supply chain’’ for the distribution of
blood-bornemetabolic signals suchas leptin to target brain areas
that control behavior.
Our data indicate that EGF treatment can restore leptin
signaling and function in obese mice with diet-induced leptin
resistance, and hasten weight loss when they return to a normal
diet, an effect that may be linked not only to improved central
leptin sensitivity but to the reinstatement of hypothalamic sensi-
tivity to other metabolic hormones such as ghrelin (Briggs et al.,l STAT3, Akt, and ERK 15 min after leptin or vehicle treatment of cultured ta-
r 15 min with 50 nM fluorescent leptin (red). Scale bar, 10 mm.
noprecipitated (IPP) clathrin-coated vesicles from tanycytes treated for 15 min
26 (10 mM), LY294002 (30 mM), and WP1066 (30 mM).
tes over an acquisition time of 30 min. (Top left panel) xy transmission image of
on 1 showing the dynamics of leptin transport from 15 to 45 min following leptin
releasing and taking up fluorescent leptin, respectively. Scale bar, 50 mm.
min after treatment.
eptin-loaded tanycytes and in the medium (released leptin) over 15 min, in the
s used in (D). STAT3 was used as a loading control for cell lysate samples. p <
groups. Values indicate means ± SEM. See also Figure S3.
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Figure 3. EGF-Mediated Activation of ERK Signaling in theMERestores the Transport of Leptin into theMBH, Increases Energy Expenditure,
and Promotes Locomotor Activity in Obese Mice
(A) EGF (1 mg/kg, 15 min) promotes ERK activation in the ME as shown by the quantitative comparison of WB (left panels; n = 4–5 per group); (right panels)
immunofluorescence labeling of pERK (white) in tanycyte cell bodies (arrowheads) and processes (arrows) contacting the pericapillary space (asterisk) in theME.
3V, third ventricle.
(B) Representative WB and quantitative comparison of leptin in ME and MBH explants from DIO (n = 4) and db/db (n = 3) mice after i.p. leptin administration
(3 mg/kg), with or without EGF treatment 15 min before sacrifice.
(C) Representative photomicrographs (top) and quantitation (bottom; n = 4) of pSTAT3 immunofluorescence after i.p. administration of leptin (3 mg/kg, 45 min)
with or without EGF treatment 15 min before sacrifice.
(D–F) Five-day food (D) and oxygen (E) consumption, and locomotor activity (F) monitoring in DIO mice injected once daily with EGF (1 mg/kg/day, red) or vehicle
(Veh, black) i.p. at 18:00 (n = 7 mice per group). Scale bars, 100 mm (A) and 200 mm (C). ****p < 0.0001; ***p < 0.001; **p < 0.01 EGF and/or leptin versus vehicle
treatment. Values shown are means ± SEM.
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McNay et al., 2012). Although we used EGF here merely to acti-
vate ERK, crosstalk between EGF and ghrelinergic pathways
could indeed occur via ERK (Nanzer et al., 2004), and EGF is a298 Cell Metabolism 19, 293–301, February 4, 2014 ª2014 Elsevier Inwell-known modulator of neural stem cell proliferation, migra-
tion, and differentiation (Kuhn et al., 1997; Sun et al., 2005).
The intriguing concept that tanycytes act as a conduit for
peripheral metabolic hormones into the brain and the role ofc.
Figure 4. EGF Treatment Accelerates the
Restoration of Leptin Sensitivity in Obese
Mice Once They Are Replaced on a Normal
Diet
(A) Body weight change over 20 weeks in stan-
dard-chow-fed mice, DIO mice, and DIO mice
replaced on a standard diet after 1 week of EGF
treatment (1 mg/kg/24 hr; DIO-R+EGF, arrow-
heads) or no EGF treatment (DIO-R) (n = 6–8 per
group).
(B) Representative WB (top) and quantitative
comparison (bottom) of leptin in MBH explants
from standard-chow-fed, DIO, DIO-R, and DIO-R+
EGF mice (n = 3–4 per group) after i.p. leptin
administration (3 mg/kg) at different time points.
(C) Body weight change in standard-chow-fed,
DIO, DIO-R, and DIO-R+EGF mice after daily i.p.
leptin administration for 3 days (n = 6–8 per group).
***p < 0.001; **p < 0.01; *p < 0.05, EGF versus
vehicle treatment and between indicated groups.
Values shown are means ± SEM.
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ology of central leptin resistance hold therapeutic potential
not only for obesity but also for cognitive impairments (McE-
wen, 2007), since leptin is also involved in regulating higher
brain functions (Harvey, 2007; Yau et al., 2012). The fact
that a CSF-mediated route for blood-borne substances into
the brain has been rarely evoked before (for an exception,
see Nakai and Naito, 1975) only adds to its interest and poten-
tial impact. Tanycytes could thus constitute the missing link in
the loop connecting behavior, hormonal changes, signal trans-
duction, central neuronal activation, and, finally, behavior
again.
EXPERIMENTAL PROCEDURES
Details are provided in the Supplemental Experimental Procedures.
Animals
Three- to four-month-old male C57Bl/6 mice (Charles River) were provided
water and standard chow (Special Diet Services) ad libitum. Some mice
received a high-fat (60% fat) diet (Research Diets). LepRdb/db (db/db) mice
were bought from Jackson Labs. All studies were approved by the Lille Univer-
sity IACUC.
Assessment of Leptin Uptake in the ME and MBH
TheME andMBHwere microdissected frommice decapitated 5, 15, or 45min
following i.p. injection of leptin (3 mg/kg) or vehicle (10 mM Tris-HCl), pooled
(two mice/sample), and subjected to western blotting. To rescue leptin trans-
port, EGF (1 mg/kg) or vehicle (10 mM acetic acid in PBS) was given 15 min
before sacrifice.
Fluorescent Leptin Assays
Fluorescent bioactive leptin or LAN (25 nmol/mouse; Cisbio Bioassays) (Vauth-
ier et al., 2013) was injected into the jugular vein of anesthetized mice, and
mice were sacrificed 5 min later to assess tanycytic leptin uptake by fluores-
cent microscopy.Cell Metabolism 19, 293–301Leptin-Neutralizing Antibody Delivery
Leptin-neutralizing antibodies (R&D Systems)
were stereotaxically injected into the third ventricle
(anteroposterior 1.7 mm, 0 mm from midline,
dorsoventral 5.6 mm) of anesthetized mice;10 min later, leptin was given i.p. in conscious mice, and mice were sacrificed
45 min later.
Immunofluorescence, Immunoprecipitation, and Western Blot
Analyses
Details are provided in the Supplemental Experimental Procedures.
Primary Cell Culture Experiments
Tanycytes were isolated as described previously (Prevot et al., 2003).
Physiological Measurements
Total energy expenditure, O2 consumption, CO2 production, food intake, and
ambulatorymovements weremeasured (Tscho¨p et al., 2012); bodyweight was
used to assess leptin sensitivity.
Statistics
Data were analyzed on GraphPad PRISM (V5.0a) using one-way or two-way
ANOVA followed by Tukey multiple-comparison tests. Differences between
two groups were determined using unpaired two-tailed Student’s t tests.
The threshold for significance was p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.cmet.2013.12.015.
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